Fiche du document
1 février 2023
- doi: 10.53738/REVMED.2023.19.812.221
- issn: 1660-9379
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.53738/REVMED.2023.19.812.221
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/36723652
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pissn/1660-9379
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_E20EDE7E809D8
info:eu-repo/semantics/embargoedAccess , Restricted: cannot be viewed until 2024-08-01 , CC BY-NC-ND 4.0 , https://creativecommons.org/licenses/by-nc-nd/4.0/
Sujets proches
Blood pressure, High Vascular hypertension High blood pressureCiter ce document
G. Wuerzner et al., « Hypertension artérielle : ce qui a changé en 2022 [Hypertension: what's new in 2022] », Serveur académique Lausannois, ID : 10.53738/REVMED.2023.19.812.221
Métriques
Partage / Export
Résumé
Our article summarizing the most important studies of the past year emphasizes the difficulty of controlling blood pressure (BP) in hypertensive patients. In addition, it discusses factors such as temperature and sodium that may influence BP, proposes new targets in pregnant hypertensive patients, and challenges the usefulness of taking an antihypertensive drug nightly. Finally, a strategy targeting endothelin blockade in resistant hypertension is presented.